{
    "2021-08-16": [
        [
            {
                "time": "",
                "original_text": "陈光明旗下新品狂卖至少110亿，最新投资动向大曝光",
                "features": {
                    "keywords": [
                        "陈光明",
                        "新品",
                        "投资动向"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "消费品",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "超100亿，这类国产新药卖得最好",
                "features": {
                    "keywords": [
                        "国产新药",
                        "销售业绩"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：医疗服务三问三答 何时会出现板块性机会？",
                "features": {
                    "keywords": [
                        "医药生物",
                        "医疗服务",
                        "板块性机会"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "银华内需精选上半年收益率-12.56%落后",
                "features": {
                    "keywords": [
                        "银华内需精选",
                        "收益率",
                        "落后"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "基金"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "银华内需精选上半年-12.56%落后 “接盘”天邦股份或最大败笔",
                "features": {
                    "keywords": [
                        "银华内需精选",
                        "天邦股份",
                        "接盘",
                        "败笔"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "基金",
                        "农业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "厉害了！1类新药卖出100亿，创新药企“猛攻”千亿肿瘤药市场，16款1类新药在路上",
                "features": {
                    "keywords": [
                        "新药",
                        "销售业绩",
                        "肿瘤药市场"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "机构已聚焦上市公司三季度经营情况！这些公司调研会信息量很大",
                "features": {
                    "keywords": [
                        "机构",
                        "上市公司",
                        "三季度",
                        "经营情况",
                        "调研"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}